Growing patient preference for noninvasive and minimally invasive surgical treatments and increasing target patient population are the key factors driving the growth of the global bone growth stimulator market. Furthermore, procedural benefits offered by bone stimulation devices are also fueling the market growth.
According to Latest Market research report Published by MarketsandMarkets the “Bone Growth Stimulators Market Size, Share, Demand and Growth Analysis, forecast” the global Market is estimated to reach USD 1.41 billion, at a CAGR of 5.4%.
Download PDF Brochure:
Major Developments in Bone Growth Stimulators Market:
- Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.
- Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion
- Zimmer Holdings merged with Biomet, Inc., a U.S.-based company engaged in the development of musculoskeletal medical products. This merger helped both companies to expand their footprints in the global musculoskeletal devices market and strengthen its position in the bone stimulators market.
key players operating in the Global Bone Growth Stimulators Market;
Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.)
Orthofix International N.V. held the leading position in the market in 2016. The company offers its non-invasive bone growth stimulators through its BioStim business segment. It has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific, and other countries. Orthofix has a strong geographic presence in 65 countries including in the U.S., the U.K., Italy, Germany, Switzerland, Austria, France, Brazil, Australia, and Puerto Rico.
Major Drivers Impacting the Bone Growth Stimulators Market;
· Growing Patient Preference for Noninvasive and Minimally Invasive Surgical Treatments
· Increasing Target Patient Population
· Procedural Benefits Offered by Bone Stimulation Devices in Bone Fracture Treatment
Speak to Our Subject Expert:
Global Bone Growth Stimulators Market Segmentation:
On the basis of product, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The bone growth stimulation devices segment accounted for the largest share of the market
On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment accounted for the largest share of the market.
Request Research Sample Pages:
